Brain stimulation treatment for bipolar disorder
- PMID: 36515461
- PMCID: PMC10210071
- DOI: 10.1111/bdi.13283
Brain stimulation treatment for bipolar disorder
Abstract
Aims: Bipolar disorders are clinically complex, chronic and recurrent disorders. Few treatment options are effective across hypomanic, manic, depressive and mixed states and as continuation or maintenance treatment after initial symptom remission. The aim of this review was to provide an up-to-date overview of research on the efficacy, tolerability and cognitive effects of electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), magnetic seizure therapy (MST), deep brain stimulation (DBS) and vagus nerve stimulation (VNS).
Methods: References included in this review were identified through multiple searches of the Embase, PubMed/MEDLINE and APA PsycINFO electronic databases for articles published from inception until February 2022. Published reviews, meta-analyses, randomised controlled trials and recent studies were prioritised to provide a comprehensive and up-to-date overview of research on brain stimulation in patients with bipolar disorders.
Results: The evidence base for brain stimulation as an add-on or alternative to pharmacological and psychological treatments in patients with bipolar disorders is limited but rapidly expanding. Brain stimulation treatments represent an opportunity to treat all bipolar disorder states, including cognitive dysfunction during euthymic periods.
Conclusion: Whilst findings to date have been encouraging, larger randomised controlled trials with long-term follow-up are needed to clarify important questions regarding treatment efficacy and tolerability, the frequency of treatment-emergent affective switches and effects on cognitive function.
Keywords: bipolar and related disorders; bipolar depression; bipolar disorder; deep brain stimulation; electroconvulsive therapy; magnetic seizure therapy; mania; transcranial direct current stimulation; transcranial magnetic stimulation; vagus nerve stimulation.
© 2022 The Author. Bipolar Disorders published by John Wiley & Sons Ltd.
Conflict of interest statement
The funding body had no role in the writing of this review or in the decision to submit it for publication.
Figures
References
-
- Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575‐1586. - PubMed
-
- Clemente AS, Diniz BS, Nicolato R, et al. Bipolar disorder prevalence: a systematic review and meta‐analysis of the literature. Braz J Psychiatry. 2015;37:155‐161. - PubMed
-
- Young AH, Rigney U, Shaw S, Emmas C, Thompson JM. Annual cost of managing bipolar disorder to the UK healthcare system. J Affect Disord. 2011;133:450‐456. - PubMed
-
- Kleine‐Budde K, Touil E, Moock J, Bramesfeld A, Kawohl W, Rössler W. Cost of illness for bipolar disorder: a systematic review of the economic burden. Bipolar Disord. 2014;16:337‐353. - PubMed
-
- Forte A, Baldessarini RJ, Tondo L, Vázquez GH, Pompili M, Girardi P. Long‐term morbidity in bipolar‐I, bipolar‐II, and unipolar major depressive disorders. J Affect Disord. 2015;178:71‐78. - PubMed
